Showing 631-640 of 4261 results for "".
Transitioning From Academia to Private Practice
https://practicaldermatology.com/issues/august-2025/transitioning-from-academia-to-private-practice/36705/YoungMD Connect recently hosted an “Ask Me Anything” mentorship session with Tina Bhutani, MD, MAS, FAAD, during which she discussed her shift in career trajectory from academia to private practice and the insights she gained along the way.On Mentorship, Open- Mindedness, and Fulfillment: A Chat with Dr. Peter Lio
https://practicaldermatology.com/youngmd-connect/wrap-ups/on-mentorship-open-mindedness-and-fulfillment-a-chat-with-dr-peter-lio/29892/Young MD Connect recently hosted a mentorship session with Dr. Peter Lio to learn from a practicing professional in the field of dermatology in a relaxed “Ask Me Anything” setting. Dr. Lio is a clinical assistant professor of dermatology and pediatrics at Northwestern University and the founding dirPsoriasis Update: Current State, Pipeline, and More
https://practicaldermatology.com/issues/july-2025/psoriasis-update-current-state-pipeline-and-more/36509/April W. Armstrong, MD, MPH, has been a driving force behind advancements in psoriasis treatments in recent years. A professor and chief of dermatology at University of California Los Angeles, Dr. Armstrong has served in leadership positions for the National Psoriasis Foundation, International PsoriFrom SDPA: JAKs, Black Boxes, and What It All Means
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-jaks-black-boxes-and-what-it-all-means/26286/Practitioners shouldn’t fear Janus kinase (JAK) inhibitors for their patients when appropriate, according to a wide-ranging expert chat at the 2024 SDPA Annual Summer Conference in San Diego. The conversation featured Matthew Zirwas, MD, a dermatologist with DOCS Dermatology, and Amy Spizuoco, DO, FSelling Skin Care in Your Practice
https://practicaldermatology.com/topics/practice-management/selling-skin-care-in-your-practice/19294/While selling skin care products in your practice may seem like it has some disadvantages, Joel Schlessinger MD believes it's worth the extra work. During this video, Joel Schlessinger MD explains why he decided to sell products in his practice. Overall, he finds that selling items he recommends toTurmeric Tonic as a Treatment in Scalp Psoriasis
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/turmeric-tonic-as-a-treatment-in-scalp-psoriasis/24460/Peter Lio, MD, leads this analysis of a study on the effectiveness of a topical turmeric preparation for mild-to-moderate scalp psoriasis. While the trial results indicated a reduction in Psoriasis Area & Severity Index (PASI) scores and improved quality of life for participants using the turmerNoah Worcester 2024: Dr. Gottlieb on Psoriatic Arthritis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gottlieb-psoriatic-arthritis/24594/Alice Gottlieb, MD, PhD, summarizes her lecture on the critical role of the dermatologist in preventing disability due to psoriatic arthritis at the 2024 Noah Worcester Dermatological Society meeting.Exosome Therapy: Explained
https://practicaldermatology.com/conferences/scale-2023/exosome-therapy-explained/20200/Jane Yoo, MD, explains exactly what exosomes are and highlights some current therapeutic uses for exosome therapy including treating hair loss and reducing redness after laser skin resurfacing.Finally: JAK Inhibitors Are Here
https://practicaldermatology.com/topics/psoriasis/finally-jak-inhibitors-are-here/20076/JAK inhibitors reach across all of dermatology, says Brett King, MD, PhD, who says the existing data is impressive and even more data are forthcoming for this class of medicine that will "change the landscape of dermatology."The Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.